Key Findings:  This systematic review of 42 meta-analyses highlights significant advancements in detecting and predicting outcomes for individuals at clinical high risk for psychosis (CHR-P), but it emphasizes the need for more robust evidence to identify effective interventions for preventing psychosis and improving outcomes in this population.
Type of Study:  Clinical Meta-analysis
Study Result:  Negative
Research Location(s):  United Kingdom
Year of Pub:  2020
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Citation:  Fusar-Poli P, et al. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention. JAMA Psychiatry. 2020; 77:755-765. doi: 10.1001/jamapsychiatry.2019.4779
Authors:  Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Koutsouleris N, McGuire P, Do KQ, Arango C